Report revives lingering rumor of a looming GSK bid for Theravance; Struggling Vivus grabs $110M loan;

 @FierceBiotech: From Researchers find possible cause of neuron dysfunction in Alzheimer's. Article | Follow @FierceBiotech

 @JohnCFierce: Another one bites the dust: Phytopharm slashes staff, scouts buyers after Parkinson's drug failure. Story | Follow @JohnCFierce

 @RyanMFierce: The top 10 moneymakers in Pharma, ordered by revenue and described in context: More | Follow @RyanMFierce

> Over the weekend, Bloomberg revived persisting rumors that GlaxoSmithKline ($GSK) was getting ready to buy out Theravance, its partner on a pair of key new drugs called Breo and Anoro. Both therapies have been pegged as likely winners at the FDA, though several analysts have cautioned on their chances in a crowded field. But with Theravance revenues pointed up, GSK may not be able to resist the urge of a takeover. It should be said, though, that this particular rumor has lingered for some time. Story

> Vivus ($VVUS) has raised $110 million in new financing from a fund managed by Pharmakon Advisers. Vivus has an option to draw down the first $50 million now and the rest of the money as needed. Vivus has been struggling in its effort to sell a new weight drug. Release

> Novartis says the FDA has OK'd its TOBI Podhaler for cystic fibrosis patients with Pseudomonas aeruginosa bacteria in the lungs. Story

Pharm​a News

 @FiercePharma: Pfizer tuberculosis drug hits FDA shortage list, with other TB remedies already scarce. Story | Follow @FiercePharma

 @EricPFierce: Momenta's Kaundinya doesn't mind some regulatory chaos in biosimilars. It allows industry to help shape pathway. Special Report | Follow @EricPFierce

> Eli Lilly CEO's pay package slides 11% to $14.6M. More

> Despite sales slide, Bristol-Myers CEO nabs 15% raise to $17.2M. Story

Medical Device News

 @FierceMedDev: Merck IUD lot hit with Hong Kong recall. Report | Follow @FierceMedDev

 @MarkHFierce: A multi-gene sequencing cancer Dx test is hitting the U.K. health system, thanks to the NHS. More | Follow @MarkHFierce

 @DamianFierce: Researchers at the Cleveland Clinic are developing a breath-based diagnostic to detect heart failure. Story | Follow @DamianFierce

> PrimeraDx teams with Quest for companion diagnostics. More

> TriReme allies with major China distributor for PAD devices. Story

> J&J recalls LifeScan glucose meters over shutdown risk. Report

Pharma Manufacturing News

> FDA fast-tracks plant for injectable on shortage list. More

> India state ups effort to root out counterfeits. Story

> Form 483 lays out latest issues dragging down Hospira. Report

> Sanofi, Transgene split cost of specialized manufacturing. Article

> Actavis puts $40M into Florida plant. More

Biotech Research News

 @EmilyMFierce: Could a canker sore treatment be the next weight-loss drug? More | Follow @EmilyMFierce

> UMD scientists test new bird flu vaccine in animals. Report

> Astellas strikes deals to hunt for dengue fever therapies. More

> New database could be a boon for genomics research. Story

> Tiny wireless sensor moves brain research forward. Item

And Finally…A new study from Tufts investigators has spotlighted the "unique resistance mechanisms of a clinical isolate of E. coli" to antibiotics. Release

Suggested Articles

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.

Pfizer’s 2017 spinout company SpringWorks has lost president and founder Lara Sullivan, M.D., who has moved over to Pyxis Oncology as its new chief.

In this week's EuroBiotech Report, Sanofi inks $2.5B Synthorx takeover and posts sutimlimab data, Roche shares bispecific results and more.